These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 29032891)

  • 1. Modulating the immune system through nanotechnology.
    Dacoba TG; Olivera A; Torres D; Crecente-Campo J; Alonso MJ
    Semin Immunol; 2017 Dec; 34():78-102. PubMed ID: 29032891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are nanotechnological approaches the future of treating inflammatory diseases?
    Rizzuto MA; Salvioni L; Rotem R; Colombo M; Zanoni I; Granucci F; Prosperi D
    Nanomedicine (Lond); 2019 Sep; 14(17):2379-2390. PubMed ID: 31414616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
    Marciani DJ
    Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view.
    Tajbakhsh A; Farahani N; Gheibihayat SM; Mirkhabbaz AM; Savardashtaki A; Hamblin MR; Mirzaei H
    Int Immunopharmacol; 2021 Jan; 90():107177. PubMed ID: 33249046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Tolerance for Autoimmune Disease and Cell Transplantation.
    Luo X; Miller SD; Shea LD
    Annu Rev Biomed Eng; 2016 Jul; 18():181-205. PubMed ID: 26928211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases.
    Serra P; Santamaria P
    Eur J Immunol; 2018 May; 48(5):751-756. PubMed ID: 29427438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-based autoimmune disease therapy.
    Serra P; Santamaria P
    Clin Immunol; 2015 Sep; 160(1):3-13. PubMed ID: 25704658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The science and medicine of human immunology.
    Pulendran B; Davis MM
    Science; 2020 Sep; 369(6511):. PubMed ID: 32973003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology for diagnosis and treatment of infectious diseases.
    Qasim M; Lim DJ; Park H; Na D
    J Nanosci Nanotechnol; 2014 Oct; 14(10):7374-87. PubMed ID: 25942798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles: "magic bullets" for targeting the immune system.
    Granucci F; Prosperi D
    Semin Immunol; 2017 Dec; 34():1-2. PubMed ID: 29173493
    [No Abstract]   [Full Text] [Related]  

  • 11. Poly(lactic acid)-based particulate systems are promising tools for immune modulation.
    Peres C; Matos AI; Conniot J; Sainz V; Zupančič E; Silva JM; Graça L; Sá Gaspar R; Préat V; Florindo HF
    Acta Biomater; 2017 Jan; 48():41-57. PubMed ID: 27826003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials for antigen-specific immune tolerance therapy.
    Park J; Wu Y; Li Q; Choi J; Ju H; Cai Y; Lee J; Oh YK
    Drug Deliv Transl Res; 2023 Jul; 13(7):1859-1881. PubMed ID: 36094655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy.
    Moorman CD; Sohn SJ; Phee H
    Front Immunol; 2021; 12():657768. PubMed ID: 33854514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation in age-related disorders and nanotechnology interventions.
    Chintapula U; Chikate T; Sahoo D; Kieu A; Guerrero Rodriguez ID; Nguyen KT; Trott D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1840. PubMed ID: 35950266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomaterial Strategies for Immunomodulation.
    Hotaling NA; Tang L; Irvine DJ; Babensee JE
    Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-Based Modulation of the Immune System.
    Fang RH; Zhang L
    Annu Rev Chem Biomol Eng; 2016 Jun; 7():305-26. PubMed ID: 27146556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects.
    Batista-Duharte A; Pera A; Aliño SF; Solana R
    Int Immunopharmacol; 2021 Jul; 96():107761. PubMed ID: 34162139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the developing immune system can prevent autoimmunity.
    Singh B
    J Autoimmun; 2000 Feb; 14(1):15-22. PubMed ID: 10648113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory Nanosystems.
    Feng X; Xu W; Li Z; Song W; Ding J; Chen X
    Adv Sci (Weinh); 2019 Sep; 6(17):1900101. PubMed ID: 31508270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.